AI model could help clinicians to understand prostate tumor’s aggressiveness

Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S.

New review suggests balanced biocide use for sustainability and health benefits

A recent review in the journal Sustainable Microbiology discusses how the use of biocides can promote well-being – but must only be used when there

August 9, 2024

Letters: The Senate fillibuster is a moderating force for better and/or worse – The Cannabist

The fillibuster moderates the Senate but is that good or bad? Re: “Is it time for America to eliminate the filibuster? Not so fast,” Oct.

October 15, 2024

Study points to a strategy for inhibiting hyper-progression of melanoma

Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of

November 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.